They found that nonenzymatic tumor cell IDO1 activity increased expression of complement factor H (CFH) and its isoform, factor H like protein (FHL-1) in human GBM, resulting in increased intratumoral Tregs and myeloid-derived suppressor cells, accelerated tumor growth and poor survival (44). This evidence concerns the gene IDO1 and glioblastoma.